Enclomiphene Citrate 7599-79-3 selective estrogen receptor antagonist

Introduction

Synonyms: trans-clomifene citrate

CAS No.: 17599-79-3

Quality: In house

Molecular Formula:   C32H36ClNO8

Formula Weight:  598.09

Product Details

Product Tags

Payment: T/T, L/C
Product Origin: China
Shipping Port: Beijing/Shanghai/Hangzhou
Production capacity: 50kg/month
Order(MOQ): 1kg
Lead Time: 3 Working Days
Storage condition: Stored in cool and dry place, sealed and keep away from light.
Package material:vial, bottle
Package size:1kg/vial, 5kg/vial, 10kg/vial, 25kg/drum
Safety information: Not dangerous goods

Introduction

Enclomiphene is primarily used as a treatment for men with persistent low testosterone as a result of secondary pogonadotropic pogonadism. In secondary pogonadotropic pogonadism, the resulting low levels of testosterone is attributed to inadequacies in the pothalamic-pituitary-gonadal axis. In contrast, primary pogonadism is caused by defects in the testes that causes them to be unable to produce the required amount of testosterone.

Enclomiphene, which stimulates the endogenous production of testosterone, is not currently known to have common adverse effects of exogenous testosterone replacement therapy, such as reduced spermatogenesis or infertility.

Specification (in house standard)

Items

Specifications

Appearance

White solid

Loss on drying ≤0.5%
Residue on ignition  ≤0.1%
Heavy metals ≤20ppm

Z isomers

≤1.0%, by HPLC

Total impurities

≤1.0%, by HPLC
Purity ≥99.0% by HPLC

 

 


  • Previous:
  • Next:

  • Write your message here and send it to us

    Professional technical engineer dedicated to guide you

    According to your actual needs, choose the most reasonable overall design and planning procedures